Enzo Biochem Revenues Relatively Flat

摘要

Enzo Biochem reported relatively flat revenues for the third quarter ended April 30, with total revenue of $25.9 million, only slightly better than the $25.8 million in the same quarter last year. Revenues from Enzo's clinical laboratory services increased about 10 percent, from $13.8 million in the third quarter of 2011 to $15.2 million in the third quarter of 2012.